GB8528761D0 - Enzyme-coupled antibodies - Google Patents
Enzyme-coupled antibodiesInfo
- Publication number
- GB8528761D0 GB8528761D0 GB858528761A GB8528761A GB8528761D0 GB 8528761 D0 GB8528761 D0 GB 8528761D0 GB 858528761 A GB858528761 A GB 858528761A GB 8528761 A GB8528761 A GB 8528761A GB 8528761 D0 GB8528761 D0 GB 8528761D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- enzyme
- coupled antibodies
- antibodies
- coupled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858528761A GB8528761D0 (en) | 1985-11-22 | 1985-11-22 | Enzyme-coupled antibodies |
EP86906886A EP0250477A1 (en) | 1985-11-22 | 1986-11-21 | Enzyme-coupled antibodies |
PCT/GB1986/000711 WO1987003205A1 (en) | 1985-11-22 | 1986-11-21 | Enzyme-coupled antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858528761A GB8528761D0 (en) | 1985-11-22 | 1985-11-22 | Enzyme-coupled antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8528761D0 true GB8528761D0 (en) | 1985-12-24 |
Family
ID=10588603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB858528761A Pending GB8528761D0 (en) | 1985-11-22 | 1985-11-22 | Enzyme-coupled antibodies |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0250477A1 (en) |
GB (1) | GB8528761D0 (en) |
WO (1) | WO1987003205A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5716990A (en) * | 1987-03-09 | 1998-02-10 | Cancer Research Campaign Technology Limited | Drug delivery systems |
US4975278A (en) * | 1988-02-26 | 1990-12-04 | Bristol-Myers Company | Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells |
NZ225599A (en) * | 1987-08-04 | 1991-09-25 | Bristol Myers Co | Antibody-enzyme conjugates and combinations with prodrugs for the treatment of tumour cells |
US5632990A (en) * | 1988-04-22 | 1997-05-27 | Cancer Research Campaign Tech. Ltd. | Treatment for tumors comprising conjugated antibody A5B7 and a prodrug |
US5759774A (en) * | 1988-05-18 | 1998-06-02 | Cobe Laboratories, Inc. | Method of detecting circulating antibody types using dried or lyophilized cells |
WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
FR2643267A1 (en) * | 1989-02-23 | 1990-08-24 | Centre Nat Rech Scient | COMPOSITIONS WITH SPECIFIC CYTOLYTIC PROPERTIES FOR APPROPRIATE TARGET CELLS AND THEIR APPLICATIONS |
EP0449998A4 (en) * | 1989-06-30 | 1992-01-15 | Brunswick Corporation | Antibody-oxidase conjugates with non-systemic substrates |
CA2069439A1 (en) * | 1989-12-15 | 1991-06-16 | Susumu Iwasa | Monoclonal antibodies, their production and use |
GB9001641D0 (en) * | 1990-01-24 | 1990-03-21 | Imp Cancer Res Tech | Compounds |
GB9503486D0 (en) | 1995-02-22 | 1995-04-12 | Secr Defence | Pharmaceuticals and assays using enzyme subunits |
US5871714A (en) * | 1997-10-16 | 1999-02-16 | Pharmacal Biotechnologies, Inc. | Compositions for controlling bacterial colonization |
NL1009834C2 (en) * | 1998-08-10 | 2000-02-11 | Stanislaus Laurens Johan Woute | Antibodies for use in the targeted and temporary treatment of humans and animals. |
GB9914057D0 (en) * | 1999-06-16 | 1999-08-18 | Ks Biomedix Ltd | Antibody therapy |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1168150A (en) * | 1981-12-18 | 1984-05-29 | The Governors Of The University Of Alberta | Targeting conjugates of albumin and therapeutic agents |
SE8401943L (en) * | 1983-04-08 | 1984-11-22 | Kureha Chemical Ind Co Ltd | ANTIBODY FOR CANDIDA FUNGI |
GB8416845D0 (en) * | 1984-07-03 | 1984-08-08 | Technology Licence Co Ltd | Monoclonal antibodies |
-
1985
- 1985-11-22 GB GB858528761A patent/GB8528761D0/en active Pending
-
1986
- 1986-11-21 EP EP86906886A patent/EP0250477A1/en not_active Withdrawn
- 1986-11-21 WO PCT/GB1986/000711 patent/WO1987003205A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1987003205A1 (en) | 1987-06-04 |
EP0250477A1 (en) | 1988-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BG47969A1 (en) | Cryoultrasonic skalpel | |
GB8501767D0 (en) | Structural members | |
GB8528761D0 (en) | Enzyme-coupled antibodies | |
GB8505487D0 (en) | Antibodies | |
GB2178931B (en) | Supports | |
EP0190683A3 (en) | Novel aminoalkylpyrdineamides | |
GB2177882B (en) | Supports | |
GB8526950D0 (en) | Supports | |
GB8508357D0 (en) | Structural members | |
GB8506706D0 (en) | Skid-sensing means | |
GB8507768D0 (en) | Fastening means | |
IL78840A0 (en) | Lattice-graded epilayer | |
GB8522593D0 (en) | Sachets | |
GB8506372D0 (en) | Antibodies | |
GB8524056D0 (en) | Forming antibodies | |
GB2170570B (en) | Securing means | |
BG40990A1 (en) | Aphrodisiatic means | |
BG39323A1 (en) | Cytoquininic means | |
BG39653A1 (en) | Cytoquininic means | |
BG40591A1 (en) | Hydroisolation means | |
BG40669A1 (en) | Herbicidic means | |
GB8515873D0 (en) | Supports | |
GB8519388D0 (en) | Supports | |
GB8608411D0 (en) | Supports | |
GB8615085D0 (en) | Supports |